Brandberg Y, Johansson H, Hellstrom M, Gnant M, et al. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer. Breast Cancer Res Treat 2020 Mar 31. pii: 10.1007/s10549-020-05602.
PMID: 32232698